Product Overview
Bio-implant designed with two cortical endplates supporting a cancellous center for ACDF procedures
Benefits
• Proven Clinical Performance: A prospective study found 100% fusion rates after 12 months in 74 ACDF patients1
• Osteoconductive: Large cancellous matrix facilitates early bone growth
• Stability: Textured surface designed to reduce migration
• Variety: Multiple footprints in both parallel and lordotic configurations to better match patient anatomy
• Sterile: Sterilized using proprietary and patented Allowash XG® technology. This technology provides a sterility assurance level of 10-6 , without compromising the implant’s inherent osteoconductive properties2
• Ambient Storage Available: This implant features Preservon®; a proprietary, glycerol-based preservation technology that allows allograft bio-implants to be stored in a fully-hydrated state at ambient temperature. Preservon eliminates lengthy thawing and rehydrating times, and does not require freezer storage, or compromise biomechanical strength3
• Uniform dimensions
1. Abla, Adnan, et al. (2005) Allograft Composite Cortical and Cancellous Bone Graft for Anterior Cervical Fusion. Contemporary Neurosurgery. 27(8).
2. Eisenlohr LM. “Allograft Tissue Sterilization Using Allowash XG®.” 2007 Bio-Implants Brief.
3. Independent sources include the Virginia Commonwealth University Medical Center and the American Association of Mechanical Engineers. Data on file at LifeNet Health, Virginia Beach, VA
Clinical Application
• Anterior Cervical Discectomy and Fusion
Alternative Products
• VG1 Cervical
• VertiGraft Fibular Spacer (https://www.lifenethealth.org/)
